Exponent, Inc. (NASDAQ: EXPO) reported Q2 EPS of $0.57, $0.06 better than the analyst estimate of $0.51. Revenue for the quarter came in at $140.5 million versus the consensus estimate of $130.83 million.

GUIDANCE

For the third quarter of 2024, as compared to the same period one year prior, Exponent anticipates:

Revenues before reimbursements to be approximately flat; and,
EBITDA1 to be 26.75% to 27.5% of revenues before reimbursements.

For the fiscal year 2024 we are raising our revenue and margin guidance. Exponent anticipates:

Revenues before reimbursements to grow in the low to mid-single digits; and,
EBITDA1 to be 27.5% to 28.0% of revenues before reimbursements.

For earnings history and earnings-related data on Exponent, Inc. (EXPO) click here.